N/A
Completed N=22
Evaluation of Lotrafilcon A Lenses Over a Three Month Period
Source: ClinicalTrials.gov NCT00931307 ↗Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Oct 2010
Primary outcomePrimary: Comfort After Insertion — 7.9 Scale of 1 to 10
Summary
The purpose of this trial is to assess the performance of a Lotrafilcon A contact lens over a 3-month period.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Comfort After Insertion |
7.9 | — |
Eligibility Criteria
Inclusion Criteria
- On examination, have ocular findings considered to be "normal" and which would not prevent a subject from safely wearing contact lenses.
- Be willing and able to follow instructions and meet the schedule of follow-up visits as defined in the informed consent.
- Be able to wear the study lenses in the available powers.
- Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
- Other protocol inclusion/exclusion criteria may apply.
Exclusion Criteria
- Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in an ophthalmic clinical trial.
- Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
- Any use of medications for which contact lens wear would be contraindicated, in the opinion of the investigator.
- History of corneal refractive surgery.
- Other protocol inclusion/exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT00931307). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.